Background illustration for clinical trials search

Paid Clinical Trials Brockton

Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

for
Multiple Myeloma, Stem Cell Transplant Complications
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT05706766

Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD),
Location: Boston MA, Philadelphia PA, Washington D.C. DC, Toronto,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 0+

Code: NCT03394365

Phase 3, Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

for
Ovarian Neoplasms, Breast Neoplasms,
Location: Boston MA, New York NY, Philadelphia PA, Glen Burnie MD,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213791

Phase 1, Recruiting

Care in Multiple Sclerosis (MS)

for
Multiple Sclerosis
Location: Boston MA, Cleveland OH, Birmingham AL, Houston TX,
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 29

Code: NCT07011914

Recruiting

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

for
Prostate Cancer
Location: Boston MA, Ottawa, Toronto, London, Ann Arbor MI,
Sponsor: University of British Columbia

Sex: Male

Age: 18+

Code: NCT04812366

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)

for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Location: Boston MA, New York NY, Cleveland OH, Durham NC,
Sponsor: Convergent Therapeutics

Sex: Male

Age: 18+

Code: NCT06549465

Phase 2, Recruiting

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

for
Chronic Graft Versus Host Disease
Location: Boston MA, New York NY, Washington D.C. DC, Toronto,
Sponsor: Sanofi

Sex: All

Age: 1 - 18

Code: NCT07116031

Phase 2, Recruiting

Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment

for
Rhegmatogenous Retinal Detachment,
Location: Boston MA
Sponsor: Massachusetts Eye and Ear Infirmary

Sex: All

Age: 18+

Code: NCT06033703

Phase 1, Phase 2, Recruiting

Yoga Breath Training to Improve Cardiorespiratory Synchrony in Spinal Cord Injury

for
Spinal Cord Injuries
Location: Cambridge MA
Sponsor: Spaulding Rehabilitation Hospital

Sex: All

Age: 18 - 60

Code: NCT06514950

Recruiting

International Rare Histiocytic Disorders Registry (IRHDR)

for
Rare Histiocytic Disorders (RHDs),
Location: Boston MA, New York NY, Toronto, Pittsburgh PA,
Sponsor: The Hospital for Sick Children

Sex: All

Age: 0+

Code: NCT02285582

Recruiting

Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait

for
Vestibular Disorder, Aging
Location: Boston MA
Sponsor: Massachusetts Eye and Ear Infirmary

Sex: All

Age: 21+

Code: NCT06688578

Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase 3, Recruiting

Optimizing Surgical Decisions in Young Adults With Breast Cancer

for
Breast Cancer Stage 0, Breast Cancer Stage I,
Location: Boston MA, New Haven CT, New York NY, Durham NC
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18 - 44

Code: NCT06275126

Recruiting

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

for
Breast Cancer, HER2-low Breast Cancer, Metastatic Breast Cancer,
Location: Boston MA, New Haven CT, The Bronx NY,
Sponsor: Ana C Garrido-Castro, MD

Sex: All

Age: 18+

Code: NCT06533826

Phase 2, Recruiting

Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System

for
Barrett's Esophagus
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 14 - 70+

Code: NCT02947971

Recruiting

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

for
Metastatic Breast Cancer
Location: Boston MA, New York NY, New Brunswick NJ, Montreal,
Sponsor: LeonaBio

Sex: All

Age: 18+

Code: NCT05696626

Phase 3, Recruiting

Gut Mini-Pill Study

for
Gut Microbiota
Location: Boston MA
Sponsor: Tufts University

Sex: All

Age: 50 - 70+

Code: NCT07220369

Recruiting

CAR-T Long Term Follow Up (LTFU) Study

for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Boston MA, Philadelphia PA, Montreal, Toronto, Hamilton,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT02445222

Phase 3, Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors, HNSCC, SCLC, NSCLC,
Location: Boston MA, New Haven CT, New York NY, Toronto,
Sponsor: Tubulis GmbH

Sex: All

Age: 18+

Code: NCT06657222

Phase 1, Phase 2, Recruiting

Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

for
PTSD - Post Traumatic Stress Disorder, PTSD, PTSD Symptoms,
Location: Boston MA, The Bronx NY, New York NY, North Canton OH,
Sponsor: COMPASS Pathways

Sex: All

Age: 18+

Code: NCT07570654

Phase 2, Phase 3, Recruiting